Flavia Jacobs

631 total citations
40 papers, 311 citations indexed

About

Flavia Jacobs is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Flavia Jacobs has authored 40 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Flavia Jacobs's work include Advanced Breast Cancer Therapies (16 papers), Breast Cancer Treatment Studies (13 papers) and Cancer Treatment and Pharmacology (10 papers). Flavia Jacobs is often cited by papers focused on Advanced Breast Cancer Therapies (16 papers), Breast Cancer Treatment Studies (13 papers) and Cancer Treatment and Pharmacology (10 papers). Flavia Jacobs collaborates with scholars based in Italy, Belgium and Spain. Flavia Jacobs's co-authors include Rita De Sanctis, Armando Santoro, Alberto Zambelli, C. Benvenuti, Elisa Agostinetto, Evandro de Azambuja, Rosalba Torrisi, Corrado Tinterri, Simone Di Maria Grimaldi and E. Barbieri and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Nutrients.

In The Last Decade

Flavia Jacobs

34 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Flavia Jacobs Italy 11 169 134 104 57 55 40 311
Maartje van Seijen Netherlands 8 176 1.0× 163 1.2× 64 0.6× 57 1.0× 54 1.0× 14 337
Valentina Magri Italy 11 207 1.2× 132 1.0× 63 0.6× 66 1.2× 56 1.0× 28 345
Saskia van de Ven Netherlands 8 242 1.4× 193 1.4× 58 0.6× 63 1.1× 64 1.2× 14 361
Carmine Valenza Italy 10 185 1.1× 87 0.6× 86 0.8× 76 1.3× 65 1.2× 47 311
Ji Won Woo South Korea 10 219 1.3× 118 0.9× 58 0.6× 82 1.4× 89 1.6× 18 352
Olga Oikonomidou United Kingdom 9 149 0.9× 119 0.9× 66 0.6× 102 1.8× 30 0.5× 28 320
Jason Mouabbi United States 7 113 0.7× 100 0.7× 64 0.6× 24 0.4× 51 0.9× 41 205
Shaheenah Dawood United Arab Emirates 9 219 1.3× 165 1.2× 70 0.7× 66 1.2× 21 0.4× 21 326
Luca Boscolo Bielo Italy 10 132 0.8× 79 0.6× 63 0.6× 58 1.0× 40 0.7× 27 211
Jurui Luo China 9 162 1.0× 144 1.1× 100 1.0× 156 2.7× 117 2.1× 21 417

Countries citing papers authored by Flavia Jacobs

Since Specialization
Citations

This map shows the geographic impact of Flavia Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavia Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavia Jacobs more than expected).

Fields of papers citing papers by Flavia Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavia Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavia Jacobs. The network helps show where Flavia Jacobs may publish in the future.

Co-authorship network of co-authors of Flavia Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Flavia Jacobs. A scholar is included among the top collaborators of Flavia Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavia Jacobs. Flavia Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Conforti, Fabio, et al.. (2025). Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses. Cancers. 17(7). 1054–1054. 5 indexed citations
3.
Jacobs, Flavia, Paola Tiberio, Chiara Pozzi, et al.. (2025). Intratumoral microbiome in breast cancer: A hidden player in tumor development, progression and treatment response. Critical Reviews in Oncology/Hematology. 217. 105035–105035.
5.
Gerosa, Riccardo, Rita De Sanctis, Flavia Jacobs, et al.. (2024). Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions. Critical Reviews in Oncology/Hematology. 196. 104324–104324. 34 indexed citations
6.
Tiberio, Paola, Matteo Castaldo, Alessandro Viganò, et al.. (2024). Empowering beyond Pain: Pain Neuroscience Education Interventions in Breast Cancer Survivorship Care. Cancers. 16(16). 2806–2806. 1 indexed citations
7.
Tiberio, Paola, Matteo Castaldo, Alessandro Viganò, et al.. (2024). Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial). Journal of Personalized Medicine. 14(7). 711–711. 2 indexed citations
8.
Sanctis, Rita De, Paola Tiberio, Flavia Jacobs, et al.. (2024). Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer. The Oncologist. 29(9). e1113–e1119. 1 indexed citations
9.
11.
Sanctis, Rita De, Paola Tiberio, Flavia Jacobs, et al.. (2023). 2105P Prophylactic role of a postbiotic microbiota-stabilizer on abemaciclib-induced diarrhea in breast cancer patients: A pilot application study. Annals of Oncology. 34. S1103–S1103.
12.
Tiberio, Paola, Lidija Antunovic, Alessandro Viganò, et al.. (2023). The Relationship among Bowel [18]F-FDG PET Uptake, Pathological Complete Response, and Eating Habits in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Nutrients. 15(1). 211–211. 5 indexed citations
13.
Jacobs, Flavia, et al.. (2023). Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer. Cancers. 15(11). 2933–2933. 15 indexed citations
14.
Jacobs, Flavia, Saverio D’Amico, C. Benvenuti, et al.. (2023). Opportunities and Challenges of Synthetic Data Generation in Oncology. JCO Clinical Cancer Informatics. 7(7). e2300045–e2300045. 16 indexed citations
15.
Jacobs, Flavia, Elisa Agostinetto, Rosalba Torrisi, et al.. (2023). Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib. Journal of Clinical Medicine. 12(5). 1775–1775. 6 indexed citations
16.
Torrisi, Rosalba, et al.. (2023). HR+/HER2– de novo metastatic breast cancer: a true peculiar entity?. Drugs in Context. 12. 1–19. 11 indexed citations
17.
Benvenuti, C., Paola Tiberio, Flavia Jacobs, et al.. (2023). Potential Role of Circulating miRNAs for Breast Cancer Management in the Neoadjuvant Setting: A Road to Pave. Cancers. 15(5). 1410–1410. 10 indexed citations
18.
Gentile, Damiano, Andrea Sagona, Bethania Fernandes, et al.. (2023). Pathologic response and residual tumor cellularity after neo-adjuvant chemotherapy predict prognosis in breast cancer patients. The Breast. 69. 323–329. 24 indexed citations
19.
Molinelli, Chiara, Flavia Jacobs, Elisa Agostinetto, et al.. (2023). Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis.. Journal of Clinical Oncology. 41(16_suppl). 1104–1104. 2 indexed citations
20.
Jacobs, Flavia, Chiara Molinelli, Diogo Martins-Branco, et al.. (2023). Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis. European Journal of Cancer. 197. 113478–113478. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026